iSelect Fund
  • Portfolio
  • Team
    • Team
    • Selection Committee
    • Portfolio Company CEOs
  • Focus Areas
    • Food & Agriculture
    • Healthcare
    • Soil Health
    • Impact Investing
    • Entrepreneurs
  • Invest
  • Content
    • Blog
    • Videos
    • Agrifood Conversations
    • FAQ
  • Contact
    • Log In
    • Register
    • My iSelect
Select Page

Novel Immune Stimulant Amplifies Direct Tumoricidal Effect of Cancer Ablation Therapies and Their Systemic Antitumor Immune Efficacy

Read more

Flywheel Secures $15M in Series B Funding

Read more

Neuros Medical Announces Key Milestones in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

Read more

Brightseed Announces Preclinical Data For Phytonutrients Targeting Liver and Metabolic Health

Read more
WOULDA, COULDA, SHOULDA

WOULDA, COULDA, SHOULDA

Missing Out is Always a Big Theil It’s 2004. you’re the first investor in a start-up social media company with 1M users and, you believe a fair valuation. You garner a board seat and watch the rest unfold. The valuation jumps to $87M in 8 months. 2 VC firms lead a... Read more

MOBILion Systems Raises $35M in Series B Funding

Read more
« Older Entries

Related Posts

  • PopBookings Funding Round
    PopBookings Raises $1 Million in Oversubscribed Funding Round
  • Neuros Medical Nerve Block Technology
    iSelect Portfolio: Neuros Medical Closes $20 Million Funding Round
  • Agrilyst
    Agrilyst Closes Strategic Funding Round
  • CRISPR in agriculture
    Benson Hill Biosystems Raises $25m Series B, Reveals CRISPR 2.0
  • Infrastructure Investing
    The $3 Trillion Problem: America's Infrastructure Crisis

Our Networks

Food & Agriculture
Healthcare

(314) 219-8688

1401 S. Brentwood Blvd.
Suite 300
St. Louis, MO 63144

Crunchbase   Medium   Twitter   LinkedIn   Facebook   YouTube

Investments in private offerings are speculative, illiquid and involve a high degree of risk. It is not unusual for an investor in a private offering to lose the entire amount of the investment. Investors who cannot afford to lose their entire investment and who cannot hold an investment for an indeterminate period should not invest in such offerings. Past performance is not indicative of future results. Securities are offered through North Capital Private Securities, member FINRA/SIPC. All information provided herein should not be relied upon to make an investment decision and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Prospective investors are recommended to consult with a financial adviser, attorney, accountant, and any other professional that can help you understand and assess the risks associated with an investment opportunity. All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in futures or other investments. North Capital Inc. is a Registered Investment Advisor and Commodities Trading Advisor. North Capital Private Securities Corporation is a registered broker dealer, member FINRA | SIPC.

The relationship between North Capital Investment Technology, North Capital Inc., and North Capital Private Securities Corporation is described in our Disclosure Documents and Code of Ethics. Check the background of this firm on FINRA's BrokerCheck © 1999-2020. All Rights Reserved. Submit a Complaint

©2020 iSelect Fund | Your use of this website signifies that you accept iSelect’s website terms and conditions of use and privacy policy.